Taylor Sandison - Net Worth and Insider Trading

Taylor Sandison Net Worth

The estimated net worth of Taylor Sandison is at least $219,194 dollars as of 2024-04-27. Taylor Sandison is the Chief Medical Officer of Cidara Therapeutics Inc and owns about 17,355 shares of Cidara Therapeutics Inc (CDTX) stock worth over $219,194. Details can be seen in Taylor Sandison's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Taylor Sandison has not made any transactions after 2024-03-11 and currently still holds the listed stock(s).

Transaction Summary of Taylor Sandison

To

Taylor Sandison Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Taylor Sandison owns 1 companies in total, including Cidara Therapeutics Inc (CDTX) .

Click here to see the complete history of Taylor Sandison’s form 4 insider trades.

Insider Ownership Summary of Taylor Sandison

Ticker Comapny Transaction Date Type of Owner
CDTX Cidara Therapeutics Inc 2024-03-11 Chief Medical Officer

Taylor Sandison Latest Holdings Summary

Taylor Sandison currently owns a total of 1 stock. Taylor Sandison owns 17,355 shares of Cidara Therapeutics Inc (CDTX) as of March 11, 2024, with a value of $219,194.

Latest Holdings of Taylor Sandison

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CDTX Cidara Therapeutics Inc 2024-03-11 17,355 12.63 219,194

Holding Weightings of Taylor Sandison


Taylor Sandison Form 4 Trading Tracker

According to the SEC Form 4 filings, Taylor Sandison has made a total of 4 transactions in Cidara Therapeutics Inc (CDTX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Cidara Therapeutics Inc is the sale of 1,033 shares on March 11, 2024, which brought Taylor Sandison around $13,844.

Insider Trading History of Taylor Sandison

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Taylor Sandison Trading Performance

GuruFocus tracks the stock performance after each of Taylor Sandison's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Taylor Sandison is 13.56%. GuruFocus also compares Taylor Sandison's trading performance to market benchmark return within the same time period. The performance of stocks bought by Taylor Sandison within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Taylor Sandison's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Taylor Sandison

Average Return

-5.08%

Average return per transaction

Outperforming Transactions

0%

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 22.88 13.56 33.9 -5.08 -47.6 -15.75
Relative Return to S&P 500(%) 23.21 12.25 25.52 -18.94 -56.27 -25.25

Taylor Sandison Ownership Network

Ownership Network List of Taylor Sandison

No Data

Ownership Network Relation of Taylor Sandison


Taylor Sandison Owned Company Details

What does Cidara Therapeutics Inc do?

Who are the key executives at Cidara Therapeutics Inc?

Taylor Sandison is the Chief Medical Officer of Cidara Therapeutics Inc. Other key executives at Cidara Therapeutics Inc include Chief Scientific Officer Leslie Tari , CFO & CBO Preetam Shah , and CHIEF LEGAL OFFICER Shane Ward .

Cidara Therapeutics Inc (CDTX) Insider Trades Summary

Over the past 18 months, Taylor Sandison made 3 insider transaction in Cidara Therapeutics Inc (CDTX) with a net sale of 46,658. Other recent insider transactions involving Cidara Therapeutics Inc (CDTX) include a net sale of 48,874 shares made by Leslie Tari , a net purchase of 100,000 shares made by Jeffrey Stein , and a net sale of 25,579 shares made by Preetam Shah .

In summary, during the past 3 months, insiders sold 4,055 shares of Cidara Therapeutics Inc (CDTX) in total and bought 0 shares, with a net sale of 4,055 shares. During the past 18 months, 7,796 shares of Cidara Therapeutics Inc (CDTX) were sold and 5,500 shares were bought by its insiders, resulting in a net sale of 2,296 shares.

Cidara Therapeutics Inc (CDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cidara Therapeutics Inc Insider Transactions

No Available Data

Taylor Sandison Mailing Address

Above is the net worth, insider trading, and ownership report for Taylor Sandison. You might contact Taylor Sandison via mailing address: 6310 Nancy Ridge Drive, San Diego Ca 92121.

Discussions on Taylor Sandison

No discussions yet.